Wave Life Sciences Ltd. financial data

Symbol
WVE on Nasdaq
Location
Singapore, Singapore
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 369% % 126%
Debt-to-equity 46% % -77%
Return On Equity -86% % 18%
Return On Assets -58% % -71%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 188,254,954 shares 22%
Common Stock, Shares, Outstanding 187,660,263 shares 23%
Entity Public Float $851,013,538 USD 74%
Common Stock, Value, Issued $1,616,478,000 USD 38%
Weighted Average Number of Shares Outstanding, Basic 168,649,795 shares 22%
Weighted Average Number of Shares Outstanding, Diluted 168,649,795 shares 22%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $8,699,000 USD -56%
Research and Development Expense $182,779,000 USD 14%
General and Administrative Expense $75,331,000 USD 28%
Operating Income (Loss) $215,383,000 USD -95%
Nonoperating Income (Expense) $11,005,000 USD -18%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $204,378,000 USD -111%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $204,378,000 USD -111%
Earnings Per Share, Basic -1.21 USD/shares -73%
Earnings Per Share, Diluted -1.21 USD/shares -73%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $602,068,000 USD 99%
Accounts Receivable, after Allowance for Credit Loss, Current $1,276,000 USD -10%
Other Assets, Current $3,075,000 USD -58%
Assets, Current $614,814,000 USD 92%
Property, Plant and Equipment, Net $7,405,000 USD -27%
Operating Lease, Right-of-Use Asset $12,458,000 USD -30%
Other Assets, Noncurrent $16,000 USD -71%
Assets $638,499,000 USD 81%
Accounts Payable, Current $15,700,000 USD -3.5%
Employee-related Liabilities, Current $18,080,000 USD 18%
Accrued Liabilities, Current $7,314,000 USD 61%
Contract with Customer, Liability, Current $44,440,000 USD -33%
Liabilities, Current $95,065,000 USD -14%
Contract with Customer, Liability, Noncurrent $7,798,000 USD 28%
Operating Lease, Liability, Noncurrent $9,405,000 USD -47%
Liabilities $112,268,000 USD -17%
Accumulated Other Comprehensive Income (Loss), Net of Tax $250,000 USD 4.6%
Retained Earnings (Accumulated Deficit) $1,326,236,000 USD -18%
Stockholders' Equity Attributable to Parent $518,357,000 USD 147%
Liabilities and Equity $638,499,000 USD 81%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $63,039,000 USD -89%
Net Cash Provided by (Used in) Financing Activities $4,155,000 USD -71%
Net Cash Provided by (Used in) Investing Activities $165,000 USD 60%
Common Stock, Shares, Issued 187,660,263 shares 23%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $58,991,000 USD -204%
Deferred Tax Assets, Valuation Allowance $326,689,000 USD 20%
Deferred Tax Assets, Gross $329,747,000 USD 19%
Operating Lease, Liability $17,766,000 USD -30%
Depreciation $875,000 USD -16%
Payments to Acquire Property, Plant, and Equipment $165,000 USD -60%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $204,366,000 USD -110%
Lessee, Operating Lease, Liability, to be Paid $19,457,000 USD -33%
Property, Plant and Equipment, Gross $56,927,000 USD 0.83%
Operating Lease, Liability, Current $8,361,000 USD 9.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $8,987,000 USD -6.2%
Lessee, Operating Lease, Liability, to be Paid, Year One $9,584,000 USD -0.07%
Operating Lease, Weighted Average Discount Rate, Percent 0.093 pure 1.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,691,000 USD -54%
Lessee, Operating Lease, Liability, to be Paid, Year Three $886,000 USD -90%
Deferred Tax Assets, Operating Loss Carryforwards $243,030,000 USD 37%
Unrecognized Tax Benefits $21,371,000 USD 2.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four $886,000 USD -90%
Additional Paid in Capital $228,365,000 USD 46%
Deferred Tax Assets, Net of Valuation Allowance $3,058,000 USD -34%
Share-based Payment Arrangement, Expense $4,953,000 USD 72%